In this regard, low-risk neuroblastoma is common in younger children with <18 months of age at the time of diagnosis1,5 and NTRK1 expression (encoding TRKA) is a strong prognostic histological marker for favorable cases, whereas TRKB (encoded by NTRK2) is associated with poor outcome2. The gene discussed is NTRK2; the disease is neuroblastoma.